日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PD-1 blockade does not enhance alloimmunization after allogeneic dendritic cell vaccination in cancer patients

PD-1阻断剂不会增强癌症患者接受同种异体树突状细胞疫苗接种后的同种免疫反应。

Planel, Severine; Vayssière, Guillaume; Maggipinto, Gianni; Leplus, Estelle; Laulagnier, Karine; Renard, Florence; Myster, Francoise; Gerard, Marie; Demedts, Ingel; Cuppens, Kristof; Pons-Tostivint, Elvire; Wauters, Els; Borm, Frank J; Sibille, Anne; Colinet, Benoît; Pérol, Maurice; Theelen, Willemijn S M E; Biesma, Bonne; Van De Kerkhove, Charlotte; Buchmeier, Eva; Althoff, Friederike C; Derijcke, Sofie; Moro-Sibilot, Denis; Cantero, Frédérique; Chaperot, Laurence; Saas, Philippe; Skrzypski, Marcin; Vansteenkiste, Johan; Plumas, Joël

Innovative therapeutic cancer vaccine PDC(∗)lung01 with or without anti-PD-1: an open-label, dose-escalation phase I/II study in non-small-cell lung cancer

创新型治疗性癌症疫苗PDC(∗)lung01联合或不联合抗PD-1抗体:一项针对非小细胞肺癌的开放标签、剂量递增I/II期研究

Vansteenkiste, J; Demedts, I; Cuppens, K; Pons-Tostivint, E; Wauters, E; Borm, F J; Sibille, A; Colinet, B; Pérol, M; Theelen, W S M E; Biesma, B; Van De Kerkhove, C; Buchmeier, E; Althoff, F C; Derijcke, S; Moro-Sibilot, D; Laulagnier, K; Halioua, E; Levy, L; Genin, M; Michel, S; Dedry, C; Duchayne, C; Collodoro, M; Renard, F; Adriaenssens, S; De Vos, B; Cantero, F; Plumas, J; Skrzypski, M

Final 3-year results from the EVIDENS study, an observational study of nivolumab in non-small cell lung cancer

EVIDENS 研究的最终 3 年结果,这是一项关于纳武利尤单抗治疗非小细胞肺癌的观察性研究

Barlesi, Fabrice; Dixmier, Adrien; Debieuvre, Didier; Raspaud, Christophe; Auliac, Jean-Bernard; Benoit, Nicolas; Bombaron, Pierre; Moro-Sibilot, Denis; Asselain, Bernard; Audigier-Valette, Clarisse; Brellier, Florence; Cotté, François-Emery; Khalife, Yaacoub; Pérol, Maurice

Surrogate markers of intestinal dysfunction associated with survival in advanced cancers

与晚期癌症患者生存相关的肠道功能障碍替代标志物

Birebent, Roxanne; Drubay, Damien; Alves Costa Silva, Carolina; Marmorino, Federica; Vitali, Giacomo; Piccinno, Gianmarco; Hurtado, Yoan; Bonato, Adele; Belluomini, Lorenzo; Messaoudene, Meriem; Routy, Bertrand; Fidelle, Marine; Zalcman, Gerard; Mazieres, Julien; Audigier-Valette, Clarisse; Moro-Sibilot, Denis; Goldwasser, François; Scherpereel, Arnaud; Pegliasco, Hervé; Ghiringhelli, François; Reni, Anna; Barlesi, Fabrice; Albiges, Laurence; Planchard, David; Martinez, Stéphanie; Besse, Benjamin; Segata, Nicola; Cremolini, Chiara; Zitvogel, Laurence; Iebba, Valerio; Derosa, Lisa

MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3 trial

在IFCT-0701 MAPS 3期试验中,miR-193b-3p和miR-132-3p作为接受一线贝伐单抗联合培美曲塞-铂类化疗的胸膜间皮瘤患者生存预后生物标志物。

Levallet, Guénaëlle; Creveuil, Christian; Léger-Vigot, Alexandre; Brosseau, Solenn; Danel, Claire; Scherpereel, Arnaud; Lantuejoul, Sylvie; Mazières, Julien; Greillier, Laurent; Audigier-Valette, Clarisse; Bergot, Emmanuel; Moro-Sibilot, Denis; Molinier, Olivier; Léna, Hervé; Monnet, Isabelle; Morin, Franck; Gounant, Valérie; Zalcman, Gérard

Real-World Use and Immunotherapy Rechallenge Outcomes with Nivolumab in Advanced Non-small Cell Lung Cancer in France: Interim Results of the LIST Study

法国晚期非小细胞肺癌患者使用纳武利尤单抗的真实世界应用及免疫疗法再挑战结果:LIST 研究的中期结果

Godbert, Benoît; Gobbini, Elisa; Decroisette, Chantal; Lena, Hervé; Khalife, Yaacoub; Brellier, Florence; Fleuriet, Anne; Zysman, Maeva; Egenod, Thomas; Moro Sibilot, Denis; Girard, Nicolas

Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer

瑞波替尼治疗ROS1融合阳性非小细胞肺癌

Drilon, Alexander; Camidge, D Ross; Lin, Jessica J; Kim, Sang-We; Solomon, Benjamin J; Dziadziuszko, Rafal; Besse, Benjamin; Goto, Koichi; de Langen, Adrianus Johannes; Wolf, Jürgen; Lee, Ki Hyeong; Popat, Sanjay; Springfeld, Christoph; Nagasaka, Misako; Felip, Enriqueta; Yang, Nong; Velcheti, Vamsidhar; Lu, Shun; Kao, Steven; Dooms, Christophe; Krebs, Matthew G; Yao, Wenxiu; Beg, Muhammad Shaalan; Hu, Xiufeng; Moro-Sibilot, Denis; Cheema, Parneet; Stopatschinskaja, Shanna; Mehta, Minal; Trone, Denise; Graber, Armin; Sims, Gregory; Yuan, Yong; Cho, Byoung Chul

Lung cancer, comorbidities, and medication: the infernal trio

肺癌、合并症和药物:这三个可怕的因素

Pluchart, Hélène; Chanoine, Sébastien; Moro-Sibilot, Denis; Chouaid, Christos; Frey, Gil; Villa, Julie; Degano, Bruno; Giaj Levra, Matteo; Bedouch, Pierrick; Toffart, Anne-Claire

Comparison of seven comorbidity scores on four-month survival of lung cancer patients

比较七种合并症评分对肺癌患者四个月生存率的影响

Pluchart, Hélène; Bailly, Sébastien; Chanoine, Sébastien; Moro-Sibilot, Denis; Bedouch, Pierrick; Toffart, Anne-Claire

Impact of polypharmacy and comorbidity on survival and systemic parenteral treatment administration in a cohort of hospitalized lung-cancer patients

多重用药和合并症对住院肺癌患者生存率和全身肠外治疗给药的影响

Pluchart, Hélène; Bailly, Sébastien; Chanoine, Sébastien; Moro-Sibilot, Denis; Bedouch, Pierrick; Toffart, Anne-Claire